Complete Filing Data
Spero Therapeutics, Inc. reported Profit Loss of $8.57 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Spero Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $8.6M | -$68.6M | $22.8M | -$46.4M | -$89.8M | -$78.3M | -$60.9M | -$41.7M | -$38.7M | -$25.5M | -$13.2M |
| Revenue * | $12.6M | $371.0K | $933.0K | $2.5M | $3.1M | $258.0K | $4.7M | $4.0M | $2.0M | $335.0K | |
| Operating Expenses | $60.5M | $121.3M | $82.3M | $95.7M | $106.2M | $88.4M | $81.4M | $46.8M | $43.7M | $33.6M | $13.3M |
| Research And Development Expense | $38.5M | $96.8M | $51.4M | $47.6M | $64.5M | $67.0M | $65.8M | $33.9M | $32.9M | $26.3M | $11.1M |
| Other Nonoperating Income Expense | $7.0K | $60.0K | -$14.0K | -$55.0K | -$395.0K | $432.0K | $740.0K | $43.0K | $1.8M | $580.0K | $174.0K |
| Operating Income Loss | $6.3M | -$73.4M | $21.5M | -$42.2M | -$88.0M | -$79.1M | -$63.2M | -$42.8M | -$41.7M | -$33.2M | -$13.3M |
| General And Administrative Expense | $21.2M | $23.7M | $25.6M | $36.5M | $41.7M | $21.4M | $15.6M | $12.9M | $10.8M | $7.2M | $2.2M |
| Grant Revenue | $7.2M | $20.6M | $7.0M | $4.9M | $15.2M | $9.1M | $13.4M | $4.0M | |||
| Comprehensive Income Net Of Tax | $22.8M | -$46.4M | -$89.8M | -$78.3M | -$60.9M | -$41.7M | -$39.9M | -$32.6M | |||
| Nonoperating Income Expense | $2.5M | $4.8M | $3.9M | -$4.2M | -$1.8M | $833.0K | $2.3M | $1.1M | |||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $0.00 | $2.0K | $5.0K | -$23.0K | $38.0K | -$28.0K | |||||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $0.00 | $2.0K | $5.0K | -$23.0K | $44.0K | -$28.0K | |||||
| Non Cash Lease Cost | $1.0M | $1.0M | $969.0K | $678.0K | $471.0K | $585.0K | $408.0K | ||||
| Net Income Loss Available To Common Stockholders Basic | -$41.7M | -$46.1M | -$29.9M | -$13.4M | |||||||
| Deferred Revenue Current | $0.00 | $368.0K | $2.1M | $4.1M | $1.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$7.4M | -$1.7M | -$13.9M | -$17.1M | -$17.9M | -$12.7M | -$3.2M | -$11.9M | -$13.3M | -$11.7M | -$28.7M | -$32.8M | -$22.5M | -$18.6M | -$19.4M | -$18.9M | -$17.5M | -$23.3M | -$25.0M | -$17.7M | -$13.2M | -$5.1M | -$10.6M | -$10.5M | -$10.0M | -$10.6M | -$13.9M | -$9.8M | -$9.2M | -$5.9M | -$7.2M | -$6.3M | -$6.1M | -$5.9M | |
| Revenue * | $0.00 | $0.00 | $12.0K | $65.0K | $114.0K | $140.0K | $218.0K | $269.0K | $223.0K | $1.1M | $896.0K | $247.0K | $708.0K | $2.1M | $7.3M | $38.0K | $51.0K | $169.0K | $696.0K | $172.0K | $67.0K | $3.8M | $1.7M | $658.0K | $463.0K | $1.2M | $993.0K | $597.0K | $249.0K | $140.0K | |||||
| Operating Expenses | $13.4M | $16.6M | $20.6M | $32.1M | $29.3M | $23.2M | $27.4M | $15.6M | $16.3M | $13.8M | $28.1M | $32.3M | $25.6M | $23.7M | $26.7M | $23.0M | $20.2M | $24.5M | $29.5M | $22.6M | $15.8M | $13.4M | $12.8M | $11.6M | $10.4M | $12.0M | $15.0M | $10.6M | $10.4M | $7.7M | $9.1M | $7.9M | $8.1M | $8.4M | |
| Research And Development Expense | $8.6M | $10.7M | $13.6M | $26.9M | $23.7M | $17.3M | $16.4M | $9.5M | $9.0M | $7.4M | $8.2M | $17.0M | $14.4M | $14.5M | $18.4M | $17.7M | $15.7M | $20.4M | $18.5M | $12.0M | $9.5M | $8.5M | $7.4M | $8.9M | $6.9M | $7.5M | $6.0M | $6.0M | |||||||
| Other Nonoperating Income Expense | $2.0K | $4.0K | $1.0K | -$26.0K | $1.0K | -$14.0K | -$10.0K | -$6.0K | -$2.0K | -$23.0K | -$10.0K | -$13.0K | -$87.0K | -$112.0K | -$118.0K | $55.0K | $889.0K | -$674.0K | -$135.0K | $135.0K | $385.0K | $472.0K | $15.0K | $172.0K | $122.0K | $402.0K | $1.2M | -$4.0K | |||||||
| Operating Income Loss | -$7.9M | -$2.4M | -$14.7M | -$18.6M | -$19.1M | -$14.0M | -$1.9M | -$12.9M | -$14.2M | -$11.8M | -$26.1M | -$30.2M | -$22.5M | -$18.5M | -$19.4M | -$19.0M | -$18.5M | -$22.8M | -$18.0M | -$13.7M | -$5.7M | -$10.9M | -$10.0M | -$10.8M | -$10.0M | -$10.2M | -$7.6M | -$7.9M | |||||||
| General And Administrative Expense | $4.2M | $5.9M | $6.8M | $5.2M | $5.5M | $5.9M | $5.7M | $6.1M | $7.3M | $6.6M | $8.1M | $15.3M | $11.2M | $9.2M | $8.3M | $5.3M | $4.5M | $4.1M | $4.1M | $3.8M | $3.9M | $3.1M | $3.1M | $3.0M | $3.7M | $3.0M | $1.7M | $1.9M | |||||||
| Grant Revenue | $2.4M | $2.4M | $763.0K | $5.7M | $4.2M | $5.1M | $2.1M | $1.9M | $1.3M | $924.0K | $1.1M | $1.8M | $2.4M | $3.0M | $7.3M | $4.0M | $1.7M | $1.5M | $2.9M | $4.5M | $2.1M | $3.9M | $1.7M | $658.0K | $463.0K | $1.2M | |||||||||
| Comprehensive Income Net Of Tax | -$3.2M | -$11.9M | -$13.3M | -$11.7M | -$28.7M | -$32.8M | $22.5M | -$18.6M | -$19.4M | -$19.0M | -$17.5M | -$23.3M | -$17.7M | -$13.1M | -$5.0M | -$10.5M | -$9.9M | -$10.7M | -$9.8M | -$9.8M | -$6.4M | ||||||||||||||
| Nonoperating Income Expense | $534.0K | $744.0K | $865.0K | $1.2M | $1.2M | $1.3M | $940.0K | $976.0K | $961.0K | $159.0K | -$2.6M | -$2.6M | $3.0K | -$30.0K | -$20.0K | $84.0K | $975.0K | -$437.0K | $268.0K | $502.0K | $624.0K | ||||||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $0.00 | $0.00 | $0.00 | $0.00 | $6.0K | -$4.0K | $0.00 | $1.0K | $4.0K | -$14.0K | $34.0K | -$35.0K | $12.0K | $5.0K | $23.0K | -$8.0K | $14.0K | -$29.0K | |||||||||||||||||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $0.00 | $0.00 | $0.00 | $0.00 | $6.0K | -$4.0K | $0.00 | $1.0K | $4.0K | -$14.0K | $34.0K | -$35.0K | $12.0K | $5.0K | $29.0K | -$8.0K | $14.0K | -$29.0K | |||||||||||||||||
| Non Cash Lease Cost | $273.0K | $254.0K | $236.0K | $221.0K | $199.0K | $110.0K | |||||||||||||||||||||||||||||
| Net Income Loss Available To Common Stockholders Basic | -$10.5M | -$10.0M | -$10.6M | -$14.8M | -$12.1M | -$12.1M | -$7.1M | -$8.3M | -$7.4M | -$7.9M | -$6.3M | ||||||||||||||||||||||||
| Deferred Revenue Current | $0.00 | $0.00 | $0.00 | $788.0K | $3.7M | $2.9M | $13.9M | $8.7M | $11.8M | $3.7M | $2.4M | $2.1M | $1.7M | $1.2M | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $59.0M | $46.1M | $106.9M | $75.9M | $88.3M | $132.0M | $74.6M | $115.5M | $84.6M | -$45.4M | -$18.6M | -$6.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $40.3M | $52.9M | $76.3M | $109.1M | $112.6M | $85.2M | $29.7M | $34.1M | $87.3M | $10.4M | $5.7M | |
| Cash And Cash Equivalents At Carrying Value | $40.3M | $52.9M | $76.3M | $109.1M | $112.6M | $85.2M | $29.7M | $34.1M | $87.3M | $10.3M | $5.7M | $256.0K |
| Retained Earnings Accumulated Deficit | -$451.1M | -$459.6M | -$391.1M | -$413.9M | -$367.5M | -$277.7M | -$199.4M | -$138.5M | -$96.8M | -$45.4M | ||
| Prepaid Expense And Other Assets Current | $1.6M | $1.9M | $4.2M | $3.4M | $8.8M | $6.1M | $4.8M | $7.5M | $1.8M | $1.3M | ||
| Other Receivables | $28.0K | $3.1M | $1.5M | $1.1M | $2.6M | $5.3M | $7.8M | $376.0K | $1.0M | $304.0K | ||
| Liabilities Current | $8.9M | $49.1M | $37.2M | $21.6M | $18.7M | $14.3M | $26.7M | $12.3M | $8.2M | $6.9M | ||
| Liabilities And Stockholders Equity | $68.9M | $110.5M | $182.4M | $124.8M | $171.1M | $153.5M | $106.1M | $129.0M | $93.5M | $13.8M | ||
| Liabilities | $9.9M | $64.4M | $75.5M | $48.9M | $82.8M | $21.4M | $31.5M | $13.2M | $8.5M | $7.4M | ||
| Assets Current | $67.3M | $107.3M | $131.2M | $113.6M | $157.9M | $139.1M | $95.4M | $124.2M | $92.1M | $11.9M | ||
| Assets | $68.9M | $110.5M | $182.4M | $124.8M | $171.1M | $153.5M | $106.1M | $129.0M | $93.5M | $13.8M | ||
| Accrued Expenses And Other Current Liabilities | $5.6M | $17.7M | $6.6M | $9.0M | $14.4M | $12.2M | $21.6M | $8.3M | $4.3M | $2.9M | ||
| Accounts Payable Current | $693.0K | $7.3M | $1.4M | $617.0K | $1.1M | $1.2M | $4.1M | $3.6M | $3.5M | $1.1M | ||
| Common Stock Value | $56.0K | $55.0K | $53.0K | $52.0K | $32.0K | $29.0K | $19.0K | $17.0K | $14.0K | |||
| Property Plant And Equipment Net | $0.00 | $2.0K | $368.0K | $1.0M | $1.7M | $2.3M | $2.9M | $1.2M | $1.5M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$12.6M | -$23.4M | -$32.8M | -$3.5M | $27.4M | $55.5M | -$4.4M | -$53.3M | $77.0M | $4.6M | ||
| Other Assets Noncurrent | $153.0K | $153.0K | $435.0K | $5.7M | $5.6M | $5.2M | $3.5M | $1.7M | ||||
| Operating Lease Right Of Use Asset | $1.5M | $3.1M | $4.2M | $5.1M | $6.5M | $7.1M | $4.9M | |||||
| Operating Lease Liability Noncurrent | $939.0K | $2.6M | $3.8M | $5.0M | $6.0M | $6.9M | $4.6M | |||||
| Operating Lease Liability Current | $2.0M | $1.7M | $1.7M | $1.7M | $1.4M | $947.0K | $928.0K | |||||
| Additional Paid In Capital Common Stock | $510.0M | $505.7M | $497.9M | $489.8M | $455.7M | $409.7M | $274.0M | $254.0M | ||||
| Other Long Term Debt Noncurrent | $91.0K | $0.00 | $87.0K | $96.0K | $138.0K | $177.0K | $249.0K | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $0.00 | $0.00 | -$2.0K | -$7.0K | $16.0K | -$28.0K | ||||||
| Accretion Amortization Of Discounts And Premiums Investments | $0.00 | -$13.0K | -$251.0K | $32.0K | $750.0K | $671.0K | ||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $3.0K | $3.0K | ||||||
| Tax Incentive Receivable Current | $846.0K | $786.0K | $922.0K | $1.9M | ||||||||
| Marketable Securities Current | $0.00 | $33.8M | $41.7M | $52.3M | $81.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q4 2016 | Q3 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $26.5M | $32.8M | $33.8M | $65.5M | $80.5M | $96.2M | $53.7M | $54.8M | $64.8M | $32.5M | $35.9M | $62.5M | $111.9M | $90.3M | $118.8M | $132.8M | $73.7M | $82.4M | $92.7M | $109.3M | $113.0M | $125.2M | $65.3M | $74.5M | -$82.2M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $48.6M | $31.2M | $48.9M | $76.3M | $63.5M | $82.3M | $93.8M | $77.7M | $96.3M | $50.4M | $45.4M | $72.1M | $112.9M | $71.6M | $77.0M | $125.2M | $65.3M | $64.4M | $45.6M | $71.1M | $49.4M | $40.5M | $48.7M | $52.6M | $25.4M | $36.3M | |||
| Cash And Cash Equivalents At Carrying Value | $48.6M | $31.2M | $48.9M | $76.3M | $63.5M | $82.3M | $93.8M | $77.7M | $96.3M | $50.4M | $45.4M | $72.1M | $112.9M | $71.6M | $77.0M | $125.2M | $65.3M | $64.4M | $45.6M | $71.1M | $49.4M | $40.5M | $48.7M | $52.6M | $25.4M | $11.3M | |||
| Retained Earnings Accumulated Deficit | -$482.6M | -$475.2M | -$473.5M | -$438.8M | -$421.6M | -$403.7M | -$442.3M | -$439.1M | -$427.1M | -$440.6M | -$429.0M | -$400.3M | -$338.2M | -$315.7M | -$297.1M | -$259.1M | -$240.2M | -$222.7M | -$174.4M | -$156.7M | -$143.6M | -$127.9M | -$117.4M | -$107.5M | -$82.2M | ||||
| Prepaid Expense And Other Assets Current | $1.2M | $1.3M | $1.5M | $2.1M | $3.2M | $3.7M | $5.4M | $8.6M | $3.5M | $1.5M | $5.0M | $8.7M | $5.8M | $4.9M | $5.2M | $7.3M | $9.2M | $5.7M | $3.7M | $6.3M | $7.9M | $1.2M | $1.2M | $1.2M | $1.0M | ||||
| Other Receivables | $1.6M | $2.5M | $668.0K | $2.7M | $4.7M | $5.0M | $3.0M | $2.1M | $1.9M | $914.0K | $1.6M | $1.6M | $2.2M | $1.9M | $8.5M | $7.1M | $4.0M | $2.7M | $5.0M | $2.1M | $456.0K | $332.0K | $794.0K | $1.2M | $537.0K | ||||
| Liabilities Current | $13.6M | $14.9M | $29.2M | $49.1M | $45.6M | $41.8M | $25.5M | $17.3M | $23.0M | $16.2M | $14.2M | $69.2M | $17.3M | $12.8M | $17.8M | $17.6M | $19.0M | $22.7M | $15.1M | $8.2M | $6.6M | $10.3M | $6.6M | $5.8M | $6.9M | ||||
| Liabilities And Stockholders Equity | $54.2M | $62.1M | $77.7M | $135.2M | $149.9M | $167.7M | $107.1M | $98.9M | $112.5M | $64.5M | $63.6M | $145.8M | $144.7M | $119.6M | $143.4M | $157.0M | $97.5M | $109.9M | $112.5M | $122.5M | $124.7M | $136.1M | $72.6M | $81.1M | $31.6M | ||||
| Liabilities | $27.7M | $29.3M | $43.9M | $69.7M | $69.4M | $71.5M | $53.4M | $44.1M | $47.7M | $32.0M | $27.7M | $83.4M | $32.8M | $29.3M | $24.6M | $24.3M | $23.8M | $27.5M | $19.5M | $12.8M | $11.3M | $10.6M | $6.9M | $6.2M | $7.3M | ||||
| Assets Current | $52.3M | $59.4M | $74.7M | $131.6M | $122.2M | $140.2M | $102.2M | $88.3M | $101.7M | $52.9M | $52.0M | $132.7M | $131.8M | $106.3M | $129.5M | $142.7M | $85.3M | $98.0M | $104.0M | $112.7M | $115.7M | $133.7M | $70.5M | $79.7M | $27.0M | ||||
| Assets | $54.2M | $62.1M | $77.7M | $135.2M | $149.9M | $167.7M | $107.1M | $98.9M | $112.5M | $64.5M | $63.6M | $145.8M | $144.7M | $119.6M | $143.4M | $157.0M | $97.5M | $109.9M | $112.5M | $122.5M | $124.7M | $136.1M | $72.6M | $81.1M | $31.6M | ||||
| Accrued Expenses And Other Current Liabilities | $7.8M | $6.7M | $8.2M | $15.3M | $10.0M | $5.4M | $6.6M | $5.6M | $8.9M | $8.1M | $8.5M | $9.1M | $11.4M | $9.0M | $13.0M | $13.6M | $16.5M | $12.9M | $11.9M | $6.4M | $5.2M | $8.6M | $5.5M | $4.5M | $4.5M | ||||
| Accounts Payable Current | $1.4M | $780.0K | $1.8M | $6.1M | $2.7M | $3.1M | $1.1M | $1.3M | $583.0K | $2.6M | $1.7M | $4.8M | $3.2M | $1.6M | $3.8M | $2.5M | $1.6M | $9.0M | $2.5M | $1.0M | $557.0K | $1.4M | $705.0K | $982.0K | $2.0M | ||||
| Common Stock Value | $56.0K | $56.0K | $56.0K | $54.0K | $54.0K | $54.0K | $53.0K | $53.0K | $53.0K | $43.0K | $35.0K | $33.0K | $32.0K | $30.0K | $30.0K | $26.0K | $21.0K | $20.0K | $19.0K | $19.0K | $17.0K | $18.0K | $14.0K | $14.0K | $0.00 | $0.00 | |||
| Property Plant And Equipment Net | $0.00 | $0.00 | $2.0K | $41.0K | $148.0K | $256.0K | $494.0K | $623.0K | $888.0K | $1.2M | $1.4M | $1.5M | $1.8M | $2.0M | $2.2M | $2.5M | $2.7M | $2.9M | $2.2M | $975.0K | $1.1M | $1.3M | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$4.0M | $5.9M | -$12.9M | -$40.5M | -$8.2M | $34.6M | $15.3M | -$34.8M | |||||||||||||||||||||
| Other Assets Noncurrent | $153.0K | $153.0K | $153.0K | $153.0K | $434.0K | $434.0K | $434.0K | $5.7M | $5.7M | $5.7M | $5.5M | $5.9M | $5.2M | $5.2M | $5.2M | $5.2M | $5.1M | $4.7M | $2.1M | $2.4M | $1.4M | ||||||||
| Operating Lease Right Of Use Asset | $2.6M | $2.8M | $3.4M | $3.6M | $3.9M | $4.4M | $4.6M | $4.9M | $5.4M | $5.6M | $6.3M | $6.5M | $6.7M | $6.9M | $7.3M | $4.9M | $4.8M | $3.9M | $4.2M | $4.4M | |||||||||
| Operating Lease Liability Noncurrent | $1.5M | $1.8M | $2.2M | $2.9M | $3.2M | $3.5M | $4.1M | $4.4M | $4.7M | $5.2M | $5.5M | $5.7M | $6.2M | $6.4M | $6.7M | $6.5M | $4.6M | $4.5M | $4.2M | $4.3M | $4.4M | ||||||||
| Operating Lease Liability Current | $1.9M | $1.8M | $1.8M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.5M | $1.4M | $1.0M | $1.0M | $980.0K | $1.5M | $936.0K | $932.0K | $442.0K | $571.0K | $639.0K | ||||||||
| Additional Paid In Capital Common Stock | $509.0M | $508.0M | $507.3M | $504.2M | $502.0M | $499.9M | $495.9M | $493.8M | $491.9M | $473.1M | $464.9M | $462.7M | $450.1M | $405.9M | $415.9M | $391.9M | $313.9M | $305.1M | |||||||||||
| Other Long Term Debt Noncurrent | $13.0K | $25.0K | $38.0K | $62.0K | $72.0K | $85.0K | $107.0K | $117.0K | $128.0K | $148.0K | $158.0K | $168.0K | $186.0K | $196.0K | $205.0K | $256.0K | $293.0K | $312.0K | |||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$6.0K | -$2.0K | -$2.0K | -$3.0K | $1.0K | $15.0K | -$19.0K | $18.0K | $6.0K | $1.0K | -$23.0K | -$15.0K | -$29.0K | |||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $0.00 | -$23.0K | -$64.0K | $53.0K | $355.0K | $45.0K | |||||||||||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | |||||||||||||
| Tax Incentive Receivable Current | $39.0K | $19.0K | $371.0K | $361.0K | $342.0K | $346.0K | $74.0K | $1.1M | $736.0K | $712.0K | $1.4M | $921.0K | $928.0K | $944.0K | $1.8M | $1.9M | |||||||||||||
| Marketable Securities Current | $0.00 | $0.00 | $49.9M | $10.6M | $27.7M | $38.6M | $2.0M | $6.0M | $24.5M | $48.3M | $32.3M | $57.0M | $90.7M | $17.9M | $22.8M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $0.00 | $221.0K | -$29.6M | $84.1M | $130.9M | $16.1M | $69.5M | $116.1M | $34.4M | $15.3M | |
| Investing Cash Flow * | $0.00 | $33.8M | $7.7M | $10.5M | $29.5M | -$83.2M | -$27.0K | -$830.0K | -$232.0K | ||
| Operating Cash Flow * | -$12.6M | -$23.4M | -$33.0M | -$7.7M | -$64.3M | -$85.9M | -$50.0M | -$39.6M | -$39.1M | -$29.0M | -$9.6M |
| Share Based Compensation | $4.3M | $7.8M | $7.9M | $9.1M | $9.4M | $4.9M | $3.8M | $2.7M | $1.4M | $180.0K | $21.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$277.0K | -$2.3M | $799.0K | -$5.2M | $2.8M | $1.2M | -$2.7M | $5.5M | $575.0K | $966.0K | $280.0K |
| Increase Decrease In Other Receivables | -$3.1M | $1.5M | $461.0K | -$1.5M | -$3.1M | -$2.4M | $7.4M | -$635.0K | $707.0K | $294.0K | $10.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$12.1M | $11.2M | -$2.4M | -$5.4M | $2.1M | -$9.1M | $13.3M | $3.6M | $1.3M | $2.3M | $409.0K |
| Increase Decrease In Accounts Payable | -$6.6M | $5.9M | $761.0K | -$484.0K | -$53.0K | -$3.0M | $564.0K | $84.0K | $2.3M | -$644.0K | $671.0K |
| Depreciation Depletion And Amortization | $0.00 | $2.0K | $367.0K | $869.0K | $646.0K | $761.0K | $750.0K | $409.0K | $363.0K | $279.0K | $11.0K |
| Increase Decrease In Other Operating Assets | $0.00 | -$282.0K | $1.0K | $3.0K | $319.0K | $1.9M | $2.9M | $1.2M | |||
| Increase Decrease In Other Noncurrent Liabilities | $91.0K | -$87.0K | -$9.0K | -$42.0K | -$39.0K | -$72.0K | -$52.0K | ||||
| Increase Decrease In Tax Incentives Receivable | -$351.0K | -$782.0K | $254.0K | -$299.0K | -$770.0K | $1.8M | $144.0K | ||||
| Payments To Acquire Marketable Securities | $0.00 | $27.0M | $43.9M | $45.7M | $89.0M | $130.2M | |||||
| Proceeds From Stock Options Exercised | $0.00 | $420.0K | $1.5M | $2.2M | $508.0K | $335.0K | |||||
| Proceeds From Sale And Maturity Of Marketable Securities | $0.00 | $60.8M | $51.5M | $56.4M | $118.8M | $49.5M | |||||
| Increase Decrease In Deferred Revenue | -$12.6M | -$370.0K | -$933.0K | $21.9M | $10.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $0.00 | $3.8M | $4.3M | $30.2M | $1.6M | $43.0M | ||||||||||||||||||||||
| Investing Cash Flow * | $0.00 | -$16.1M | $3.0M | $27.8M | $24.7M | -$22.8M | ||||||||||||||||||||||
| Operating Cash Flow * | -$4.0M | $5.9M | -$12.9M | -$28.2M | -$15.5M | -$23.3M | -$10.9M | -$12.0M | -$7.0M | |||||||||||||||||||
| Share Based Compensation | $1.0M | $714.0K | $1.6M | $2.2M | $2.1M | $2.0M | $1.9M | $1.9M | $2.2M | $2.1M | $1.3M | $3.2M | $2.3M | $2.2M | $2.0M | $1.2M | $1.2M | $1.1M | $981.0K | $933.0K | $933.0K | $705.0K | $661.0K | $614.0K | $931.0K | $61.0K | $62.0K | $60.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$363.0K | -$510.0K | $164.0K | -$31.0K | -$869.0K | $860.0K | $448.0K | -$604.0K | -$131.0K | |||||||||||||||||||
| Increase Decrease In Other Receivables | -$2.4M | $3.5M | $781.0K | -$661.0K | $3.2M | -$5.0M | $80.0K | $208.0K | -$190.0K | |||||||||||||||||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$9.5M | -$1.2M | -$111.0K | -$5.3M | $624.0K | -$9.3M | -$3.4M | $165.0K | $434.0K | |||||||||||||||||||
| Increase Decrease In Accounts Payable | -$5.5M | $1.7M | -$34.0K | $3.7M | $2.7M | $4.8M | -$3.0M | -$2.5M | -$82.0K | |||||||||||||||||||
| Depreciation Depletion And Amortization | $0.00 | $113.0K | $189.0K | $159.0K | $189.0K | $184.0K | $95.0K | $87.0K | ||||||||||||||||||||
| Increase Decrease In Other Operating Assets | $0.00 | -$1.0K | $0.00 | -$285.0K | $1.2M | -$433.0K | ||||||||||||||||||||||
| Increase Decrease In Other Noncurrent Liabilities | $0.00 | -$49.0K | -$11.0K | -$10.0K | -$9.0K | -$44.0K | $11.0K | |||||||||||||||||||||
| Increase Decrease In Tax Incentives Receivable | -$1.0K | -$772.0K | $233.0K | $62.0K | $45.0K | $159.0K | ||||||||||||||||||||||
| Payments To Acquire Marketable Securities | $0.00 | $27.0M | $3.0M | $4.0M | $25.8M | $22.8M | ||||||||||||||||||||||
| Proceeds From Stock Options Exercised | $0.00 | $188.0K | $93.0K | $539.0K | $59.0K | |||||||||||||||||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $0.00 | $10.9M | $6.0M | $31.9M | $50.6M | |||||||||||||||||||||||
| Increase Decrease In Deferred Revenue | -$12.0K | -$141.0K | -$224.0K | -$246.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.15 | -$1.27 | $0.43 | -$1.23 | -$2.91 | -$3.52 | -$3.35 | -$2.60 | -$17.82 | -$95.87 | -$53.11 |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 30.9M | 22.4M | 18.2M | 16.0M | 2.6M | 312.2K | 252.8K | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Authorized | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 60.0M | 60.0M | 60.0M | 60.0M | 0.00 | |
| Common Stock Shares Outstanding | 56.4M | 54.6M | 53.0M | 52.5M | 32.4M | 29.3M | 19.2M | 17.2M | 14.4M | 0.00 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Issued | 56.4M | 54.6M | 53.0M | 52.5M | 32.4M | 29.3M | 19.2M | 17.2M | 14.4M | 0.00 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 3.2M | 3.2M | 2.7K | 3.2K | 0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 3.2M | 3.2M | 2.7K | 3.2K | 0.00 | ||
| Weighted Average Number Of Shares Outstanding Basic | 56.0M | 54.0M | 52.7M | 37.6M | 30.9M | ||||||
| Weighted Average Number Of Diluted Shares Outstanding | 59.0M | 54.0M | 53.0M | 37.6M | 30.9M | ||||||
| Earnings Per Share Basic | $0.15 | $-1.27 | $0.43 | $-1.23 | $-2.91 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.13 | -$0.03 | -$0.25 | -$0.32 | -$0.33 | -$0.24 | -$0.06 | -$0.23 | -$0.25 | -$0.33 | -$0.87 | -$1.01 | -$0.70 | -$0.63 | -$0.66 | -$0.86 | -$0.85 | -$1.22 | -$1.31 | -$0.95 | -$0.74 | -$0.29 | -$0.60 | -$0.60 | -$0.69 | -$0.74 | -$1.59 | -$36.02 | -$36.21 | -$21.60 | -$25.68 | -$23.23 | -$25.30 | -$21.51 |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 32.6M | 32.1M | 29.7M | 29.4M | 21.9M | 20.6M | 19.6M | 19.1M | 18.7M | 17.7M | 17.2M | 17.7M | 17.5M | 14.4M | 14.4M | 9.3M | 335.3K | 334.8K | 330.1K | 324.5K | 318.9K | 313.4K | 290.9K | |||||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Common Stock Shares Authorized | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 60.0M | 60.0M | 60.0M | 60.0M | 60.0M | 60.0M | 60.0M | 60.0M | 60.0M | 60.0M | 60.0M | 61.9M | |||||||||
| Common Stock Shares Outstanding | 56.3M | 56.2M | 55.9M | 54.3M | 54.0M | 53.9M | 53.0M | 52.6M | 52.6M | 42.9M | 35.1M | 32.8M | 32.2M | 29.7M | 29.7M | 26.0M | 21.0M | 20.3M | 18.7M | 18.7M | 17.3M | 18.2M | 14.4M | 14.4M | 335.3K | |||||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||
| Common Stock Shares Issued | 56.3M | 56.2M | 55.9M | 54.3M | 54.0M | 53.9M | 53.0M | 52.6M | 52.6M | 42.9M | 35.1M | 32.2M | 29.7M | 29.7M | 26.0M | 21.0M | 20.3M | 18.7M | 18.7M | 17.3M | 18.2M | 14.4M | 14.4M | 335.3K | ||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.3M | 3.2M | 3.2M | 3.2M | 3.2M | 5.0K | 5.0K | 2.7K | 2.7K | 3.2K | 2.2K | |||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.3M | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 5.0K | 5.0K | 2.7K | 2.7K | 3.2K | 2.2K | ||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 56.3M | 56.0M | 55.4M | 54.1M | 54.0M | 53.5M | 52.7M | 52.6M | 52.5M | 35.9M | 33.0M | 32.6M | 32.1M | 29.7M | ||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 56.3M | 56.0M | 55.4M | 54.1M | 54.0M | 53.5M | 52.7M | 52.6M | 52.5M | 35.9M | 33.0M | 32.6M | 32.1M | 29.7M | ||||||||||||||||||||
| Earnings Per Share Basic | $-0.13 | $-0.03 | $-0.25 | $-0.32 | $-0.33 | $-0.24 | $-0.06 | $-0.23 | $-0.25 | $-0.33 | $-0.87 | $-1.01 | $-0.70 | $-0.63 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $4.3M | $7.8M | $7.9M | $9.1M | $9.4M | $4.9M | $3.8M | $2.7M | $1.4M | $180.0K | $21.0K |
| Investment Income Interest | $2.5M | $4.7M | $3.9M | $1.1M | $346.0K | $401.0K | $1.3M | $1.1M | |||
| Stock Issued During Period Value Stock Options Exercised | $420.0K | $1.5M | $2.2M | $508.0K | $335.0K | ||||||
| Stock Issued During Period Value New Issues | $221.0K | $14.2M | $7.8M | $77.9M | $15.3M | ||||||
| Foreign Currency Transaction Gain Loss Before Tax | $0.00 | -$10.0K | -$13.0K | $330.0K | $18.0K | -$373.0K | -$83.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.0M | $714.0K | $1.6M | $2.2M | $2.1M | $2.0M | $1.9M | $1.9M | $2.2M | $2.1M | $1.3M | $3.2M | $2.3M | $2.2M | $2.0M | $1.2M | $1.2M | $1.1M | $981.0K | $933.0K | $933.0K | $705.0K | $661.0K | $614.0K |
| Investment Income Interest | $532.0K | $740.0K | $864.0K | $1.2M | $1.2M | $1.3M | $950.0K | $982.0K | $963.0K | $208.0K | $111.0K | $72.0K | $90.0K | $82.0K | $98.0K | $29.0K | $86.0K | $237.0K | $403.0K | $367.0K | $239.0K | |||
| Stock Issued During Period Value Stock Options Exercised | $0.00 | $231.0K | $188.0K | $826.0K | $277.0K | $93.0K | $201.0K | $269.0K | $539.0K | $51.0K | $300.0K | $59.0K | $146.0K | $51.0K | ||||||||||
| Stock Issued During Period Value New Issues | $220.0K | $6.1M | $577.0K | $3.6M | $1.1M | $4.1M | $46.4M | $7.3M | $9.0M | $38.0K | $8.3M | $1.5M | ||||||||||||
| Foreign Currency Transaction Gain Loss Before Tax | $0.00 | $11.0K | $19.0K | -$453.0K | $95.0K | -$8.0K |
Most recent annual filing with the SEC: March 26, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.